L948-3557 Screening compound: 4-{2-[3-(2,4-difluorophenyl)-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carbonyl}-N,N-dimethylaniline

L948-3557 Screening compound: 4-{2-[3-(2,4-difluorophenyl)-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carbonyl}-N,N-dimethylaniline
L948-3557 Screening compound: 4-{2-[3-(2,4-difluorophenyl)-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carbonyl}-N,N-dimethylaniline alternative view

Chemical Structure Depiction of ChemDiv screening compound L948-3557
4-{2-[3-(2,4-difluorophenyl)-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carbonyl}-N,N-dimethylaniline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L948-3557

Molecular Formula

C21H20F2N4O2 (C21 H20 F2 N4 O2)

Compound Name

4-{2-[3-(2,4-difluorophenyl)-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carbonyl}-N,N-dimethylaniline

IUPAC name

4-{2-[3-(24-difluorophenyl)-124-oxadiazol-5-yl]pyrrolidine-1-carbonyl}-NN-dimethylaniline

SMILES

CN(C)c(cc1)ccc1C(N(CCC1)C1c1nc(-c(ccc(F)c2)c2F)no1)=O

InChI

InChI=1S/C21H20F2N4O2/c1-26(2)15-8-5-13(6-9-15)21(28)27-11-3-4-18(27)20-24-19(25-29-20)16-10-7-14(22)12-17(16)23/h5-10,12,18H,3-4,11H2,1-2H3/t18-/m0/s1

InChI Key

JZDQZSLYVJPNAG-SFHVURJKSA-N

MDL Number (MFCD)

MFCD27489193

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

398.41

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.119

Distribution Coefficient, logD

4.119

Water Solubility, LogSw

-4.24

Polar Surface Area

51.157

Acid Dissociation Constant (pKa)

25.42

Base Dissociation Constant (pKb)

8.18

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.60

L948-3557 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Ion Channels Focused Library (26372 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Cardiovascular
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
Targets:
  • Proteases
  • Ion Channels
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L948-3557 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L948-3557?
Check Price and Availability of L948-3557, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L948-3557 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L948-3557
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L948-3557
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L948-3557 available by request